Welcome to LookChem.com Sign In|Join Free
  • or
N-(6-Methoxy-4-methylpyridin-3-yl)acetamide is a chemical compound characterized by the molecular formula C11H14N2O2. It is an acetamide derivative featuring a pyridine ring that is substituted with both a methoxy and a methyl group. N-(6-Methoxy-4-methylpyridin-3-yl)acetamide may hold promise in pharmaceutical applications, potentially acting as a key component in the synthesis of a variety of organic compounds. Further exploration and testing are required to fully elucidate its properties and potential applications.

76013-32-6

Post Buying Request

76013-32-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76013-32-6 Usage

Uses

Used in Pharmaceutical Industry:
N-(6-Methoxy-4-methylpyridin-3-yl)acetamide is used as a building block for the synthesis of various organic compounds, particularly in the pharmaceutical industry, due to its unique structural features that may contribute to the development of new drugs with specific therapeutic properties.
Used in Chemical Research:
In the field of chemical research, N-(6-Methoxy-4-methylpyridin-3-yl)acetamide is utilized for studying the properties and reactions of acetamide derivatives with pyridine rings. This can lead to a better understanding of the compound's behavior and its potential applications in various chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 76013-32-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,0,1 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 76013-32:
(7*7)+(6*6)+(5*0)+(4*1)+(3*3)+(2*3)+(1*2)=106
106 % 10 = 6
So 76013-32-6 is a valid CAS Registry Number.

76013-32-6Relevant academic research and scientific papers

THERAPEUTIC INHIBITORY COMPOUNDS

-

Paragraph 00631, (2018/03/26)

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.

Pyrazolopyridines. Part 5. Preparation and Reactions of Pyrazolopyridines

Chapman, David,Hurst, Jim

, p. 2398 - 2404 (2007/10/02)

A series of pyrazolopyridines has been prepared by nitrosation of 3-acetamido-4-methylpyridines and subsequent rearrangement and cyclisation of the N-acetyl-N-nitroso-compounds produced.The reactions of the pyrazolopyridines have been investigated. 1- and 2-Acetyl and 1- and 2-benzyl compounds were obtained and their structures elucidated spectroscopically.The ring system readily undergoes electrophilic substitution in the 3-position. 7-Chloropyrazolopyridine has been shown to be more susceptible to nucleophilic substitution than the isomeric 5-chloro-compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 76013-32-6